Skip to content

Nuvalent, Inc. NUVL Shares (Basic)

Shares (Basic) at other companies

Pfizer logo
PfizerPFE
5.7B+0.3%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
1B+20.4%
Summit Therapeutics logo
Summit TherapeuticsSMMT
775.5M+5.1%
Exelixis logo
ExelixisEXEL
258.3M-7.3%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
198.1M+5.3%
Incyte logo
IncyteINCY
199.3M+2.9%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s shares (basic)?
Nuvalent, Inc. (NUVL) reported shares (basic) of 78.7M in Q1 2026.
How has Nuvalent, Inc.'s shares (basic) changed year-over-year?
Nuvalent, Inc.'s shares (basic) increased by 9.9% year-over-year, from 71.6M to 78.7M.
What is the long-term trend for Nuvalent, Inc.'s shares (basic)?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s shares (basic) has grown at a 48.0% compound annual growth rate (CAGR), from 60M to 288.3M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.